Table 2.
Lymphocytes percentage in multiple sclerosis (MS) patients and healthy controls (HCs)
| MS patients | HCs | p value | |
|---|---|---|---|
| Number of subjects | 46 | 14 | |
| T lymphocyte, mean ± SD | 57.35 ± 18.06 | 68.29 ± 10.45 | 0.05* |
| B lymphocytes, mean ± SD | 9.85 ± 6.76 | 13.5 ± 5.37 | 0.13 |
| CD4+ lymphocytes, mean ± SD | 36.72 ± 16.38 | 42.36 ± 10.3 | 0.26 |
| CD8+ lymphocytes, mean ± SD | 16.91 ± 6.73 | 20.29 ± 6.5 | 0.16 |
| CD4/CD8 ratio, mean ± SD | 2.46 ± 1.49 | 2.3 ± 0.92 | 0.83 |
| Natural killer lymphocytes, mean ± SD | 14.61 ± 11.31 | 11.07 ± 5.5 | 0.30 |
| CD3+CD20+ lymphocytes, mean ± SD | 0.32 ± 0.63 | 0 ± 0 | 0.07 |
| Naïve regulatory T cells, mean ± SD | 0.18 ± 0.31 | 0.03 ± 0.05 | 0.02* |
| Memory regulatory T cells, mean ± SD | 0.7 ± 0.45 | 0.61 ± 0.38 | 0.38 |
| Naïve regulatory B cells, mean ± SD | 0.52 ± 0.71 | 0.36 ± 0.32 | 0.34 |
| Memory regulatory B cells, mean ± SD | 1.17 ± 1.54 | 1.43 ± 1.89 | 0.51 |
MS multiple sclerosis, HCs healthy controls, SD standard deviation
* Logistic regression adjusted for age and sex (p < 0.05)